Elsevier

Value in Health

Volume 23, Issue 5, May 2020, Pages 566-573
Value in Health

Themed Section: Precision Medicine
Addressing Challenges of Economic Evaluation in Precision Medicine Using Dynamic Simulation Modeling

https://doi.org/10.1016/j.jval.2020.01.016Get rights and content
Under an Elsevier user license
open archive

Highlights

  • Simulation modeling methods such as discrete event simulation may be better suited than traditional state-transition cohort models to address the complexity and specific challenges of economic evaluation of precision medicine interventions.

  • Simulation models can be used for patient-level analyses of care pathways and have the ability to deal with system complexity of multiple tests, diagnostic performance, and testing and treatment sequences that present particular challenges for precision medicine.

Abstract

Objectives

The objective of this article is to describe the unique challenges and present potential solutions and approaches for economic evaluations of precision medicine (PM) interventions using simulation modeling methods.

Methods

Given the large and growing number of PM interventions and applications, methods are needed for economic evaluation of PM that can handle the complexity of cascading decisions and patient-specific heterogeneity reflected in the myriad testing and treatment pathways. Traditional approaches (eg, Markov models) have limitations, and other modeling techniques may be required to overcome these challenges. Dynamic simulation models, such as discrete event simulation and agent-based models, are used to design and develop mathematical representations of complex systems and intervention scenarios to evaluate the consequence of interventions over time from a systems perspective.

Results

Some of the methodological challenges of modeling PM can be addressed using dynamic simulation models. For example, issues regarding companion diagnostics, combining and sequencing of tests, and diagnostic performance of tests can be addressed by capturing patient-specific pathways in the context of care delivery. Issues regarding patient heterogeneity can be addressed by using patient-level simulation models.

Conclusion

The economic evaluation of PM interventions poses unique methodological challenges that might require new solutions. Simulation models are well suited for economic evaluation in PM because they enable patient-level analyses and can capture the dynamics of interventions in complex systems specific to the context of healthcare service delivery.

Keywords

economic evaluation
precision medicine
simulation model

Cited by (0)